SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0000903423-13-000669
Filing Date
2013-11-25
Accepted
2013-11-25 18:02:06
Documents
1
Period of Report
2013-10-25

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT dyuksaerie_f3a.html 3/A  
1 OWNERSHIP DOCUMENT dyuksaerie_f3a.xml 3/A 4388
  Complete submission text file 0000903423-13-000669.txt   5827
Mailing Address 301 COMMERCE STREET SUITE 3300 FORT WORTH TX 76102
Business Address
DUYK GEOFFREY M (Reporting) CIK: 0001202090 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-36152 | Film No.: 131242038

Mailing Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709
Business Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709 919-313-9650
AERIE PHARMACEUTICALS INC (Issuer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)